Using TT, CMV and influenza as model pathogens, we demonstrated that in a primary in vitro stimulation response, T-cell proliferation and cytokine production were inhibited by TRAM-34 and were relatively insensitive to ShK treatment. This evidence concerns the gene SHPK and influenza.